Influence of tumor microenvironment on the different breast cancer subtypes and applied therapies
CF Almeida, G Correia-da-Silva, N Teixeira… - Biochemical …, 2024 - Elsevier
Despite the significant improvements made in breast cancer therapy during the last
decades, this disease still has increasing incidence and mortality rates. Different targets …
decades, this disease still has increasing incidence and mortality rates. Different targets …
Aromatase inhibitors for the treatment of breast cancer: An overview (2019–2023)
N Bhatia, S Thareja - Bioorganic Chemistry, 2024 - Elsevier
Aromatase inhibition is considered a legitimate approach for the treatment of ER-positive
(ER+) breast cancer as it accounts for more than 70% of breast cancer cases. Aromatase …
(ER+) breast cancer as it accounts for more than 70% of breast cancer cases. Aromatase …
[HTML][HTML] Estrogens and estrogen receptor modulators in cancer research and therapy
O Treeck - Cancers, 2023 - mdpi.com
Estrogens affect oncogenesis and tumor progression in a variety of cancer entities. In breast
cancer, endocrine therapy (ET), including selective estrogen receptor modulator (SERM) …
cancer, endocrine therapy (ET), including selective estrogen receptor modulator (SERM) …
[HTML][HTML] Role of natural products in tumor therapy from basic research and clinical perspectives
Z Wang, Z Liu, J Qu, Y Sun, W Zhou - Acta Materia Medica, 2024 - scienceopen.com
Cancer is the leading cause of morbidity and mortality worldwide and is an important barrier
to lengthening life expectancy in every country. Natural products are receiving increased …
to lengthening life expectancy in every country. Natural products are receiving increased …